alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › administration

administration

6 studies tagged administration, dated 2004-11-01 to 2017-11-07. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease 2017-11-07
  2. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease 2016-11-30
  3. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats 2016-10-11

Studies

6 studies carry this tag.

Date range

2004 to 2017

Top journals

  • Experimental neurology 2
  • Glia 1
  • International journal of pharmaceutics 1
  • Molecular neurobiology 1
  • Pharmacology, biochemistry, and behavior 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Experimental neurology 2017-11-07 Biomarkers

    Dysfunction in the resolution of inflammation may play a key role in Alzheimer's disease (AD).

  2. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. International journal of pharmaceutics 2016-11-30 Biomarkers

    Quercetin has been identified as a promising compound with a neuroprotective potential against age-related neurodegenerative diseases such as Alzheimer's disease (AD).

  3. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Molecular neurobiology 2016-10-11 Biomarkers

    Alzheimer's disease (AD) is associated with reduced insulin level and impairment of insulin receptor (IR) signaling in the brain, which correlates to amyloid pathology, neuroinflammation, and synaptic neurotoxicity.

  4. Postischemic administration of Z-Ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Pharmacology, biochemistry, and behavior 2007-08-24 Biomarkers

    Previous studies have demonstrated that Z-Ligustilide (LIG), a characterized phthalide constituent present in numerous medical Umbelliferae plants, has significant neuroprotective effects in transient forebrain ischemia and permanent cerebral focal ischemia.

  5. Diverse microglial responses after intrahippocampal administration of lipopolysaccharide

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Glia 2006-03-01 Biomarkers

    Inflammation has been argued to play a primary role in the pathogenesis of Alzheimer's disease by contributing to the development of neuropathology and clinical symptoms.

  6. Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Experimental neurology 2004-11-01 Biomarkers

    Inflammation has been argued to play a primary role in the pathogenesis of Alzheimer's disease (AD).

All topic tags with their study counts